Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Retraction Note: Alterations of ATM and CADM1 in chromosomal 11q22.3-23.2 region are associated with the development of invasive cervical carcinoma.

Human genetics·2025
Same author

Preventable cancer cases and deaths attributable to tobacco smoking in Korea from 2015 to 2030.

Epidemiology and health·2025
Same author

Declining Prevalence of Human Papillomavirus Co-Infections Among Young Japanese Women With Cervical Cancer and Its Precursors.

Journal of medical virology·2024
Same author

Distinct roles of types 1 and 2 interferons in human eosinophil regulation: A multi-omics analysis.

Allergy·2024
Same author

Mapping adipocyte interactome networks by HaloTag-enrichment-mass spectrometry.

Biology methods & protocols·2024
Same author

Should all fellows in gynecologic oncology have experience performing radical hysterectomies, or should this be limited to select surgeons? Is medical oncology the future direction for gynecologic oncologists?

Archives of gynecology and obstetrics·2024

Related Experiment Video

Updated: Jun 8, 2026

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
09:48

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

Published on: September 12, 2019

Cervical Cancer Working Group report.

Ryo Konno1, Satoru Sagae, Hiroyuki Yoshikawa

  • 1Department of Obstetrics and Gynecology, Jichi Medical University Saitama Medical Center, 1-847 Amanumacho, Ohmiya-ku, Saitama 330-8503, Japan. kryo772007@yahoo.co.jp

Japanese Journal of Clinical Oncology
|September 28, 2010
PubMed
Summary
This summary is machine-generated.

Cervical cancer prevention strategies, including screening and human papillomavirus (HPV) vaccination, are crucial for reducing disease burden. Increased public awareness and government support are vital for improving survival rates and quality of life.

More Related Videos

Generation and Genetic Manipulation of Human Cervical Organoids
10:29

Generation and Genetic Manipulation of Human Cervical Organoids

Published on: March 10, 2026

Related Experiment Videos

Last Updated: Jun 8, 2026

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
09:48

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

Published on: September 12, 2019

Generation and Genetic Manipulation of Human Cervical Organoids
10:29

Generation and Genetic Manipulation of Human Cervical Organoids

Published on: March 10, 2026

Area of Science:

  • Oncology
  • Public Health
  • Epidemiology

Background:

  • Cervical cancer poses a significant disease burden in Asia.
  • Human papillomavirus (HPV) type 16 is a primary oncogenic driver.
  • Varied screening and vaccination program effectiveness across Asian countries.

Purpose of the Study:

  • To summarize the disease burden of cervical cancer in Asia.
  • To evaluate the impact of screening and vaccination programs.
  • To provide recommendations for improved cervical cancer prevention.

Main Methods:

  • Review of national cervical cancer screening and vaccination programs in Asian countries (Korea, Japan, India, Australia) and comparative analysis with the UK.
  • Modeling of HPV vaccination impact on future cervical cancer incidence.
  • Assessment of public awareness and government support for prevention initiatives.

Main Results:

  • Korea has high screening coverage (∼80%), while Japan's coverage has declined (∼24%) despite historical success.
  • India lacks a screening program and awareness.
  • Australia's comprehensive program, including free HPV immunization, has significantly reduced incidence and mortality.
  • Modeling suggests HPV vaccination could reduce cervical cancer cases by 73% in Japan.
  • UK demonstrates high uptake due to government education and funding, contrasting with Japan's need for greater emphasis on women's health.

Conclusions:

  • Heightened public awareness of cervical cancer prevention, focusing on screening and vaccination, is essential.
  • Implementing effective, affordable screening (e.g., HPV-based) and vaccination programs can improve survival.
  • Governmental commitment to education and funding is critical for program success.